BC99 Clinical Research——Weight Management
As of February 2026, more than 1,000 subjectsacross all age groups-including children, adults, andthe elderly-have been enrolled in clinical trialsinvolving BC99. Among the clinical interventionregimens, the maximum daily dosage administeredwas 48 billion CFU, with the longest interventionduration lasting up to 12 weeks.No serious adverse events (SAEs) associated withBC99 were reported in any dosage group or agesubgroup throughout the entire clinical trial period.
April 14View:28
MORE >